Philip I. Datlow

Array ( [id] => 2962094 [patent_doc_number] => 05264431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-23 [patent_title] => 'Polycyclic conjugates' [patent_app_type] => 1 [patent_app_number] => 7/973133 [patent_app_country] => US [patent_app_date] => 1992-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20719 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 328 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/264/05264431.pdf [firstpage_image] =>[orig_patent_app_number] => 973133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3099053 [patent_doc_number] => 05314886 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-24 [patent_title] => 'N-substituted lactams useful as cholecystokinin antagonists' [patent_app_type] => 1 [patent_app_number] => 7/968617 [patent_app_country] => US [patent_app_date] => 1992-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22970 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 297 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/314/05314886.pdf [firstpage_image] =>[orig_patent_app_number] => 968617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2995050 [patent_doc_number] => 05362725 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-08 [patent_title] => 'Tetracyclic compounds having anti-allergic and anti-asthmatic activities and their use' [patent_app_type] => 1 [patent_app_number] => 7/962037 [patent_app_country] => US [patent_app_date] => 1992-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27959 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 747 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/362/05362725.pdf [firstpage_image] =>[orig_patent_app_number] => 962037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3454680 [patent_doc_number] => 05378698 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-03 [patent_title] => 'Benzothiazepine derivatives' [patent_app_type] => 1 [patent_app_number] => 7/960851 [patent_app_country] => US [patent_app_date] => 1992-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7669 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/378/05378698.pdf [firstpage_image] =>[orig_patent_app_number] => 960851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2988771 [patent_doc_number] => 05266695 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-30 [patent_title] => 'Composite densification with benzoxazines' [patent_app_type] => 1 [patent_app_number] => 7/956713 [patent_app_country] => US [patent_app_date] => 1992-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4298 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/266/05266695.pdf [firstpage_image] =>[orig_patent_app_number] => 956713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3530550 [patent_doc_number] => 05583130 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Benzo-fused lactams promote release of growth hormone' [patent_app_type] => 1 [patent_app_number] => 7/951681 [patent_app_country] => US [patent_app_date] => 1992-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31525 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1273 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/583/05583130.pdf [firstpage_image] =>[orig_patent_app_number] => 951681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3077319 [patent_doc_number] => 05296595 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-03-22 [patent_title] => 'Method of enantioselectively inserting a carbene' [patent_app_type] => 1 [patent_app_number] => 7/950836 [patent_app_country] => US [patent_app_date] => 1992-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 7779 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/296/05296595.pdf [firstpage_image] =>[orig_patent_app_number] => 950836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2885063 [patent_doc_number] => 05268381 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-07 [patent_title] => 'Aminoalkyl-benzothiazolinone and -benzoxazolinone compounds having a high 5-HT1A affinity' [patent_app_type] => 1 [patent_app_number] => 7/945492 [patent_app_country] => US [patent_app_date] => 1992-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11238 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 267 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/268/05268381.pdf [firstpage_image] =>[orig_patent_app_number] => 945492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3050549 [patent_doc_number] => 05283240 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-01 [patent_title] => '8-substituted-dibenz [b,f] [1,4] oxazepine-10(11)-carboxylic acid, substituted hydrazides for the treatment of osteoporosis' [patent_app_type] => 1 [patent_app_number] => 7/939261 [patent_app_country] => US [patent_app_date] => 1992-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15739 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/283/05283240.pdf [firstpage_image] =>[orig_patent_app_number] => 939261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3010188 [patent_doc_number] => 05281590 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-25 [patent_title] => '2-H and 3-alkoxy or hydroxy-8-substituted-dibenz[b,f]-[1,4]oxazepine-10(11)-carboxylic acid, substituted hydrazides for the treatment of osteoporosis' [patent_app_type] => 1 [patent_app_number] => 7/939262 [patent_app_country] => US [patent_app_date] => 1992-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9899 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/281/05281590.pdf [firstpage_image] =>[orig_patent_app_number] => 939262 [rel_patent_id] =>[rel_patent_doc_number] =>)